A Hybrid Systems Biology And Systems Pharmacology Investigation Of Zingerone’s Efects On Reconstructed Human Epidermal Tissues Part 1

Please contact oscar.xiao@wecistanche.com for more information

Background: As individuals live longer, elderly populations can be expected to face issues. This pattern urges researchers to investigate the aging concept further to produce successful anti-aging agents. In the current study, the effects of zingerone (a natural compound) on epidermal tissues were analyzed using a bioinformatics approach. Methods: For this purpose, we chose the GEO dataset GSE133338 to carry out the systems biology and systems pharmacology approaches, ranging from identifying the differentially expressed genes to analyzing the gene ontology, determining similar structures of Zingerone and their features (ie., anti-oxidant, anti-inflammatory, and skin disorders), constructing the gene-chemicals network, analyzing gene-disease relationships, and validating significant genes through the evidence presented in the literature.

Results: The post-processing of the microarray dataset identified thirteen essential genes among control and Zingerone-treated samples. cistanche powder The procedure revealed various structurally similar chemical and herbal compounds with possible skin-related effects. Additionally, we studied the relationships of differentially expressed genes with skin-related diseases and validated their direct connections with skin disorders under the evidence available in the literature. Also, the analysis of the microarray profiling dataset revealed the critical role of interleukins as a part of the cytokines family on skin aging progress.

Please click here to know more

Conclusions: Zingerone, and potentially any constituents of Zingerone (e.g., their similar compound scan functionality), can be used as therapeutic agents in managing skin disorders such as skin aging. However, the beneficial effects of Zingerone should be assessed in other models(i.e., human or animal) in future studies.

Keywords: Zingerone, Skin-aging, Systems biology, Systems pharmacology, Interleukin, Gene-disease association, Gene-chemicals network, Similar compounds, Skin disorder

Background

The skin, consisting of the epidermis, dermis, and subcutaneous layers, is the body's largest organ and forms a physical barrier between the external environment and the internal environment that protects and maintains. As the population ages, the epidermis and dermis are the primary targets for various changes that encourage the development of novel anti-aging therapeutic agents [1]. Physical and chemical environmental factors such as UV radiation and xenobiotics play significant roles in the oxidative stress of skin cells by altering the involved signaling pathways, immunosuppression, and producing reactive oxygen species(ROS) and photosensitivity diseases [2]. Various skin anti-aging treatment procedures are available, including topical retinoids, peels (e.g., salicylic acid), botulinum neurotoxin, soft tissue fillers, collagens, hyaluronic acid, autologous fat, allogenic and synthetic products, lasers, surgical procedures, and endocrinological therapies, as well as other alternatives such as phytohormones[3]. The reports showed that the use of natural compounds has promising results in reducing UV-induced effects of skin aging, which have made them play the primary role in cosmetic-related sciences[4].

(4-(4-hydroxy-3-methoxyphenyl)-2-bu-Zingeronetanone) is an inexpensive and nontoxic phenolic alkenone structure derived from Ginger(Zingiber officinale Rosc), which is a widely used herb in pharmaceutical and food industries throughout the world (e.g., China, Greece, and India)[5-7]. cistanche salsa extract Zingerone is a result of gingerol dehydration while being cooked or dried [5]. The main pharmacological properties of Zingerone include anti-oxidative, immune-stimulant, anti-inflammatory, and anti-cancer effects [8]. Previous studies reported the anti-ultraviolet B(UVB)radiation activity of Zingerone in protecting the epidermis [9].

Cistanche can anti-aging

Zingerone likely acts as a neuroprotective agent by blocking the apoptotic pathway, thus preventing oxidative stress and limiting inflammation [10]. It is thought that polyphenolic compounds called Zingerone are present in ginger and have potent anti-oxidant properties, exhibit free radical scavenging activity, and provide resistance to oxidative stress[11]. cistanche stem Various protective effects of Zin-gerone have been reported in lead-induced toxicity[12], streptozotocin/high fat diet-induced type 2 diabetes[13], rheumatoid arthritis [14], lipopolysaccharide-induced oxidative stress,DNA damage, cytokine storms [15], experimental colon carcinogenesis [16],alloxan-induced oxidative stress [17], cyclophosphamide-induced organ toxicity [11], and cisplatin (cis-diamminedichloroplati-num (I)-induced jejunal toxicity[18].Zingerone substantially decreased NF-KB, TGF-β, TNF-α, IL-1β, IL-6, and Hs-CRP levels while considerably increasing I-10 levels and restoring anti-oxidant enzyme levels [14]. Thus, when given to animals (e.g., Wistar rats) exposed to the above-mentioned toxicities and diseases, Zingerone may reduce oxidative stress, inflammation, and multi-organ damage.

To the best of the author's knowledge, no investigation has used systems biology and systems pharmacology approaches to determine significantly differentially expressed genes between control tissues and those treated by Zingerone. In this study, we used the available microarray gene expression profiling datasets to meet this aim. The functional and cellular mechanisms of identified genes were also inspected. Then, various network analyses, including gene disease and gene chemicals, were performed. Finally, the effects of chemical and herbal compounds similar to Zingerone's structure were studied in detail, and the validation of potential significant genes was reviewed based on evidence found in the literature.

Methods

A summary of the current research workflow is illustrated as a flowchart diagram, as shown in Fig.1. Data source The dataset used in this study is publicly available from the gene expression omnibus (GEO)database repository of the national center for biotechnology information (NCBI)(ie, https://www.ncbi.nlm.nih.gov/geo/)with the GPL17692 [HuGene-2_1-st] Affymetrix Human Gene 2.1 ST Array [transcript(gene) version] platform. The only available GEO dataset, GSE133338, included six reconstructed human epidermal (RHE) tissues treated by Zingerone (n=3)and water control (n=3), as shown in Fig.1.

Differentially expressed genes(DEGs) between two types of tissues

Dr. Richard Simon and the BRB-ArrayTools Development Team developed a genomics analytical tool, BRB-ArrayTools(v4.6.1, stable version), to determine potent DEGs. Several steps, including GEO dataset import, gene filtering (ie., |fold changel≥1), normalization (i.e., quantile normalization), and annotation (i.e., "pd. hugene.2.1.st"R package [19]), were required to identify the significant DEGs. The BRB-ArrayTools used the german (guanine-cytosine robust multi-array analysis)algorithm to map the probe intensities into their corresponding gene expression values by discarding existing noise. The comparison between two treated groups resulted in the identification of significant DEGs using values of 10,000 and 1 for univariate permutation tests and the threshold of fold change. The obtained DEG results were significant at p≤0.05.

Gene ontology and functional enrichment analyses DAVID v.6.8(Database for Annotation, Visualization, and Integrated Discovery), which is freely available at http://david.abcc.ncifcrf.gov/summary.jsp, provided the evaluation of the gene ontology (GO). This evaluation included cellular components, molecular functions, and biological processes of DEGs [20,21]. The threshold for the EASE score of a modified Fisher exact p-value was set to its default value of 0.1.

Effectiveness and similarity structure analyses of Zingerone

The canonical SMILES(simplified molecular-input line-entry system) string for the Zingerone structure (shown in Fig. 2a) was obtained from the PubChem compound database(https://pubchem.ncbi.nlm.nih.gov/compound)[22]. Each string of SMILES was used for PubChem similarity structure and ADME prediction using online web

server tools, i.e, SwissADME [23-25], SwissSimilarity [26], and SwissTargetPrediction [27]. The SwissADME web server covers the drug design and discovery by computing several parameters, including physicochemical descriptors, ADME-related parameters, pharmacokinetic properties, drug-likeness effect, and studying medicinal chemistry friendliness of SMILES structure.

The similarity criteria for the PubChem similarity structure and the SwissSimilarity tools were 0.92 and 0.50, respectively. Finally, we screened the literature for any existing evidence for functionalities of similar compounds.

Gene-disease and gene-chemicals network analyses We extracted the related diseases with evidence according to the significant genes obtained through the user-friendly DisGeNET (i.e., http://www.disgenet.org/)platform, derived from the literature on human gene-disease associations [28]. cistanche tubulosa benefits and side effects Additionally, the involvement of obtained DEGs affected by Zingerone treatment in several specific diseases (and possibly in skin-related disorders) was thoroughly screened through the literature studies to confirm and validate whether such genes are expressed as to potential biomarkers of the disease. Furthermore, we constructed and analyzed the gene-chemicals network from the NetworkAnalyst 3.0 webserver to reveal potent associations between genes and compounds available in the literature[29].

Results

Since missing any possible genes could affect the final results, all of the genes included in the microarray dataset are considered. The data preprocessing and class comparison approach using a two-sample t-test revealed a total of sixty probe IDs, from which only thirteen DEGs were available as annotated genes. Four genes were downregulated, and nine were upregulated (as shown in Fig. 2b), along with their gene expression levels between control and Zingerone-treated samples. The DAVID functional annotation tool revealed that two cellular components(i.e., (i) GO:0005615, and extra-cellular space with four involved genes TNFRSF11B, CTSL, ENDOU, and SPACA5 and (ii)GO:0005576, an extracellular region with three involved genes TNFRSF11B, CTSL, and ENDOU)were found significant. The kappa values of 1.00 and 0.80 indicated a very high level of similarity between the two GO terms. Moreover, the statistical measurement values for GO:0005615 and GO:0005576 have folded enrichments of 7.73 and 4.85, Bonferroni values of 0.09 and 0.72, and Benjamini values of 0.088 and 0.60, and false discovery rate(FDR) values of 0.088 and 0.6, respectively. The detailed inspection of GO terms shows that their corresponding child terms have various relationships and cross-references with GO:0005576 and GO:0005615. The relationships involving the extracellular space suggest that interleukin-35 complex, interleukin-27, interleukin-23, and interleukin-12 were part of GO:0005615. Moreover; the relationships involving the extracellular region were mainly part of the extracellular isoamylase complex, extra-cellular ferritin complex, extracellular space, extracellular vesicle, and extracellular matrix, to mention a few. Four types of interleukins (i.e.,interleukin-1, interleukin-6, interleukin-34, and interleukin-34 alpha)had direct relationships with cross-references of GO:0005615 (for more information, refer to https://www.ebi.ac.uk/QuickGO/GTerm?id=GO:0005615). Several interleukin types, including interleukin-12 alpha, interleukin-23 alpha, interleukin-17, interleukin-1 alpha, interleukin-1 beta, and interleukin-6, were related to cross-references of GO:0005576(derived from https://www.ebi.ac.uk/QuickGO/GTerm?id=GO:0005576).

The assessment of the absorption, distribution, metabolism, and excretion (ADME)of the Zingerone structure using the bioavailability radar (Fig. 3a) indicates the high bioactive drug-likeness property and represents the lipophilicity, molecular weight, solubility, and flexibility properties positioned in the pink area. Moreover, physicochemical and lipophilicity properties (Lipinski's rule of five)(i.e., molecular weight:194.23 g/mol, number of rotatable bonds:4, number of H-bond acceptors:3, number of H-bond donors:1, and consensus Log Po/w:1.79)show no violations. cistanche tubulosa extract The water solubility parameters, including Log S (ESOL), Log S (Ali), and Log S (SIL-COS-IT), demonstrate very soluble, very soluble, and soluble features, respectively. Also, the pharmacokinetic properties reveal a high level of gastrointestinal absorption and only CYP1A2 inhibitory function among other cytochrome enzyme inhibitors.

The SwissTargetPrediction analysis results in a total of 100 target proteins for Zingerone, among which enzymes, secreted proteins, nuclear receptors, and oxidoreductases make up the highest percentages (Fig. 3b). A further inspection of similar structures through the SwissSimilarity and PubChem uncovered two FDA-approved drugs (i.e., Nabumetone and Maso-procol), two experimental drugs(i.e., Matairesinol and 3-(4-hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)propane-1-one), and three Zingiber constituents (i.e.,6-Shogaol, 6-Paradol, and 6-Gingerol)(listed in Table 1). The inspection also revealed their validated anti-inflammatory and anti-oxidant properties, as well as the confirmed skin disorders, such as skin anti-aging, through the evidence provided in the literature. The gene-disease relationship outcomes from the Dis-GeNET(accompanied by the relevant evidence from the literature) are summarized in Table 2. The results indicate that the DEGs influence various diseases, including skin-related disorders. Furthermore, the construction of the gene-chemicals network shows the involvement of seven DEGs that are directly associated with different chemicals. Only four of them (i.e., TNFRSF11B, DNLZ, OR9Il, and MIR614) are related to twenty-three skin-related compounds (shown in Fig. 4).

Discussion

Sunlight is a source of ultraviolet (UV) radiation, which can harm the skin. Skin aging, which results from exposure to UV radiation, is often classified into three major categories(ie., UV-A, UV-B, and UV-C). UV-A makes up 95% of the UV rays that reach the Earth's surface, and

where R is a type of free radical such as hydroxyl, per-oxyl, alkoxyl, or alkyl radicals, and O or OCH, are the remained free radicals [46,47]. Similarly, the mechanism of action of these chemicals, given their anti-inflammatory properties, applies through radical scavenging activities [48].

Additionally, it has been established that the immune system can function in the human body as a double-edged sword in which immunity and immunopathology simultaneously provide benefits and do damage by balancing innate and adaptive immunity [49]. In a recent review, Zouboulis et al. stated that"In clinical practice, 'to look better does not mean to look younger."[50].

Skin, the largest organ of the human body, inherits all immune system functions for better studying inflammation, autoimmunity, and cancer [51]. Skin aging is a multistep process that can be promoted through sun exposure, which may result in epidermal changes and photo-aging [52]. Various studies have proposed the benefits of natural compounds such as curcumin and its analogs in treating skin disorders such as skin aging [53, 54].

In the current investigation, the effects of Zingerone on epidermal tissues have been studied while considering the differentially expressed genes and the cellular components involved. As an outcome, without any exceptions, the assessed genes play roles in involving interleukins, which are a well-known group of cytokines expressed mainly by leukocytes. Cytokines, which are produced by the Langerhans cells of the skin's immune system, were reported to play a significant role in skin aging [55]. Based on the identified differentially expressed genes and their effective cellular components in terms of GO, including GO:0005615 and GO:0005576, eighteen and four types of interleukins were determined to play roles in extracellular space and region, respectively.

In line with our results, Shirato et al. found that ETAS 50 could prevent skin aging by decreasing both UV-B-induced L-6 and IL-1 beta expressions(56, 57). Also, Guo et al. reported that adipose-derived stem cells could secrete several interleukins (e.g.,interleukin-Iβ,inter-leukin-8, interleukin-9,interleukin-12, interleukin-15, and interleukin-17)to inhibit skin aging [58].Exercising could also affect interleukin-15 levels, thus preventing skin aging [59]. Interleukin 17 (or IL-17A)has a direct relationship with the stimulation of IL-23, making them a golden IL-23/IL-17 axis in age-associated inflammation and attenuating skin aging via acetyl Zingerone treatment through IL-17A stimulation [60, 61].

In summary, the current study proposed a hybrid systems biology and systems pharmacology procedure to identify the functional mechanisms and successful effects of Zingerone treatment. The proposed procedure considers the impact of similar compounds for stimulating the involved interleukins family on skin aging and their anti-oxidant and anti-inflammatory properties. More experimental studies on human and animal models are required to confirm the present results, as Zingerone's effects on cellular and molecular mechanisms on skin aging are still unclear.

Conclusions

The prominent role of herbal remedies is clear to the research and scientific communities. Skin aging and other types of skin disorders have attracted the attention of people throughout the world. In this regard, several drugs and chemicals have been proposed for anti-aging purposes. In this study, a computational and statistical procedure was considered to investigate the effect of Zin-gerone on skin aging at the cellular and genomic levels. Additionally, compounds that are structurally similar to Zingerone and their impacts on skin-related diseases were studied.

Furthermore, the gene-disease association and gene-chemicals network analyses revealed undeniable direct connections between genetics and skin disorders, including skin aging. Finally, various types of interleukins were found to have vital roles in attenuating skin aging. However, further research using human or animal models is required to confirm the effects of Zingerone determined in the present study.

This article is extracted from Amjad et al. Egypt J Med Hum Genet (2021) 22:90